Front Line COVID-19 Critical Care Alliance

The Front Line COVID-19 Critical Care Alliance (FLCCC) is a non-profit medical organization dedicated to developing and disseminating treatment protocols for COVID-19. Founded in 2020 by a group of critical care specialists, the alliance focuses on repurposing existing, low-cost generic medications to improve patient outcomes across all stages of the disease. Their work includes the development of the MATH+ Hospital Treatment Protocol and the I-MASK+ Prevention and Early Outpatient Treatment Protocol. The organization is widely recognized for its advocacy of ivermectin and other repurposed drugs, though its recommendations have often diverged from those of major public health agencies. In addition to acute COVID-19, the FLCCC provides guidance on managing Long COVID and post-vaccination syndromes. The alliance operates primarily through clinical research review, physician education, and public advocacy.